{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:17:09Z","timestamp":1760645829289},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.nucmedbio.2011.03.007","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T03:43:09Z","timestamp":1310182989000},"page":"1035-1041","source":"Crossref","is-referenced-by-count":2,"title":["Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid"],"prefix":"10.1016","volume":"38","author":[{"given":"Jonathon A.","family":"Nye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nashwa","family":"Jarkas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bital","family":"Savir-Baruch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Voll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon M.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark M.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2011.03.007_bb0005","first-page":"1030","article-title":"The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues","volume":"19","author":"Busch","year":"1959","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.nucmedbio.2011.03.007_bb0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197204272861707","article-title":"Sugar and amino acid transport by cells in culture \u2014 differences between normal and malignant cells","volume":"286","author":"Isselbacher","year":"1972","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","article-title":"Role of amino acid transport and countertransport in nutrition and metabolism","volume":"70","author":"Christensen","year":"1990","journal-title":"Physiol Rev"},{"issue":"3A","key":"10.1016\/j.nucmedbio.2011.03.007_bb0020","first-page":"1989","article-title":"Differential Expression and functional characterization of system l amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells","volume":"26","author":"Kim","year":"2006","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.nucmedbio.2011.03.007_bb0025","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/jso.20257","article-title":"Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma","volume":"90","author":"Kobayashi","year":"2005","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1476-5586(04)80054-X","article-title":"L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma","volume":"6","author":"Lin","year":"2004","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.nucmedbio.2011.03.007_bb0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","article-title":"Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines","volume":"1514","author":"Yanagida","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10.1016\/j.nucmedbio.2011.03.007_bb0040","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ijc.21866","article-title":"L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors","volume":"119","author":"Nawashiro","year":"2006","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.nucmedbio.2011.03.007_bb0045","first-page":"1367","article-title":"Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-l-tyrosine in vitro and in vivo","volume":"40","author":"Heiss","year":"1999","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.nucmedbio.2011.03.007_bb0050","first-page":"1338","article-title":"Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine","volume":"32","author":"Wienhard","year":"1991","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2011.03.007_bb0055","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10555-008-9154-7","article-title":"Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography","volume":"27","author":"McConathy","year":"2008","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"10.1016\/j.nucmedbio.2011.03.007_bb0060","first-page":"1055","article-title":"1-aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent","volume":"20","author":"Washburn","year":"1979","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.nucmedbio.2011.03.007_bb0065","first-page":"331","article-title":"Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors","volume":"40","author":"Shoup","year":"1999","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0070","first-page":"56","article-title":"Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET\/CT in prostate carcinoma","volume":"48","author":"Schuster","year":"2007","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0075","first-page":"46","article-title":"A preliminary study of anti-1-amino-3-18F-fluorocyclobutyl-1-carboxylic acid for the detection of prostate cancer","volume":"48","author":"Oka","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.03.007_bb0080","first-page":"1516","article-title":"Characterization of the two enantiomers of anti-18F-FACPC as PET tumor agents","volume":"51","author":"Jarkas","year":"2010","journal-title":"J Nucl Med Meeting Abstracts"},{"key":"10.1016\/j.nucmedbio.2011.03.007_bb0085","first-page":"1266","article-title":"Pilot evaluation of 1-amino-2-[18F] fluorocyclopentane-1-carboxylic acid (anti-2-[18F] FACPC) PET-CT in recurrent prostate carcinoma","volume":"51","author":"Savir-Baruch","year":"2010","journal-title":"J Nucl Med Meeting Abstracts"},{"issue":"18","key":"10.1016\/j.nucmedbio.2011.03.007_bb0090","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1021\/jm100841m","article-title":"(R,S)-Anti-1-amino-2-[18F]fluorocyclopentyl-1-carboxylic acid: synthesis from racemic 2-benzyloxycyclopentanone and biological evaluation for brain tumor imaging with positron emission tomography","volume":"53","author":"Jarkas","year":"2010","journal-title":"J Med Chem"},{"issue":"6","key":"10.1016\/j.nucmedbio.2011.03.007_bb0095","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0969-8043(03)00029-0","article-title":"Improved synthesis of anti-[18F]FACBC: improved preparation of labeling precursor and automated radiosynthesis","volume":"58","author":"McConathy","year":"2003","journal-title":"Appl Radiat Isot"},{"issue":"2","key":"10.1016\/j.nucmedbio.2011.03.007_bb0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1021\/jm900556s","volume":"53","author":"Yu","year":"2010","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.nucmedbio.2011.03.007_bb0105","first-page":"1734","article-title":"Performance characteristics of a newly developed PET\/CT scanner using NEMA standards in 2D and 3D modes","volume":"45","author":"Mawlawi","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2011.03.007_bb0110","series-title":"Radiation dose to patients from radiopharmaceuticals. Publication 53. Vol 18\/1-4","author":"ICRP","year":"1988"},{"issue":"3","key":"10.1016\/j.nucmedbio.2011.03.007_bb0115","first-page":"538","article-title":"MIRDOSE: personal computer software for internal dose assessment in nuclear medicine","volume":"37","author":"Stabin","year":"1996","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2011.03.007_bb0120","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.bmc.2009.01.032","article-title":"Stereoselective synthesis and biological evaluation of syn-1-amino-3-[18F]fluorocyclobutyl-1-carboxylic acid as a potential positron emission tomography brain tumor imaging agent","volume":"17","author":"Yu","year":"2009","journal-title":"Bioorg Med Chem"},{"issue":"11","key":"10.1016\/j.nucmedbio.2011.03.007_bb0125","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/jm010242p","article-title":"Synthesis of syn- and anti-1-amino-3-[18F]fluoromethyl-cyclobutane-1-carboxylic acid (FMACBC), potential pet ligands for tumor detection","volume":"45","author":"Martarello","year":"2002","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0130","first-page":"205","article-title":"Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-l-tyrosine for tumor imaging","volume":"40","author":"Wester","year":"1999","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.nucmedbio.2011.03.007_bb0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00259-003-1118-0","article-title":"Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-l-tyrosine","volume":"30","author":"Pauleit","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.nucmedbio.2011.03.007_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03165656","article-title":"Problems of [S-methyl-11C]-l-methionine as a protein synthesis marker in the pancreas","volume":"4","author":"Fujibayashi","year":"1990","journal-title":"Ann Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2011.03.007_bb0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s002590050265","article-title":"Estimation of internal absorbed dose of l-[methyl-11C]methionine using whole-body positron emission tomography","volume":"25","author":"Deloar","year":"1998","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"10.1016\/j.nucmedbio.2011.03.007_bb0150","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2967\/jnumed.107.040097","article-title":"Biodistribution and radiation dosimetry of the synthetic nonmetabolized amino acid analogue anti-18F-FACBC in humans","volume":"48","author":"Nye","year":"2007","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2011.03.007_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0969-8051(00)00198-0","article-title":"Whole-body kinetics and dosimetry of cis-4-[18F]fluoro-l-proline","volume":"28","author":"B\u00f6rner","year":"2001","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2011.03.007_bb0160","unstructured":"Savir-Baruch B, Schuster DM, Jarkas N, et al. Pilot Evaluation of anti-1-amino-2-[18F]fluorocyclopentane-1-carboxylic acid (anti-2-[18F]FACPC) PET-CT in recurrent prostate carcinoma. Molecular Imaging and Biology. in press."},{"issue":"4","key":"10.1016\/j.nucmedbio.2011.03.007_bb0165","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/rpd\/ncn187","article-title":"ICRP publication 103: recommendations of the ICRP\u2020","volume":"129","author":"Charles","year":"2008","journal-title":"Radiat Prot Dosimetry"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805111001090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:24:15Z","timestamp":1560374655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805111001090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0969805111001090"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2011.03.007","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}